Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| NAC (N-Acetyl Cysteine) | Palmitoylethanolamide (PEA) | |
|---|---|---|
| Category | Supplements | Supplements |
| Standard Dose | 600-1200mg daily | — |
| Timing | On empty stomach for best absorption, 30 min before meals. Split doses if >600mg. | — |
| Cycle Duration | Cycle 8 weeks on, 2 weeks off (to avoid potential downregulation of endogenous GSH production) | — |
| Evidence Level | strong_human | Strong |
NAC is a precursor to L-cysteine, the rate-limiting substrate for glutathione (GSH) synthesis via glutamate-cysteine ligase. It directly replenishes intracellular GSH, the master endogenous antioxidant. NAC also modulates glutamatergic neurotransmission by stimulating the cystine-glutamate antiporter (system Xc-), influencing extrasynaptic glutamate levels. Additionally, it acts as a mucolytic by cleaving disulfide bonds in mucus glycoproteins.
600-1200mg daily
On empty stomach for best absorption, 30 min before meals. Split doses if >600mg.
Cycle 8 weeks on, 2 weeks off (to avoid potential downregulation of endogenous GSH production)
Endocannabinoid-like lipid that activates PPAR-alpha and indirectly enhances endocannabinoid tone. Potent anti-inflammatory and analgesic without acting directly on CB1/CB2. Reduces mast cell activation, neuroinflammation, and chronic pain.
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →